Yono, Japan

Katsuhiko Kojima


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Katsuhiko Kojima

Introduction

Katsuhiko Kojima is a notable inventor based in Yono, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 2 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

Kojima's latest patents include innovative 1-methylcarbapenem derivatives. The first patent describes a 1-methylcarbapenem compound characterized by a specific formula, where R¹ can represent hydrogen or a C₁-C₄ alkyl group, and R² can represent hydrogen or an ester residue. This compound exhibits excellent antibacterial activity, making it effective as a preventive or remedy for infections. The second patent also focuses on 1-methylcarbapenem derivatives, detailing a compound that showcases similar properties and potential applications in treating bacterial infections.

Career Highlights

Katsuhiko Kojima is currently associated with Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing antibacterial treatments, contributing to the overall health and well-being of society.

Collaborations

Kojima has collaborated with notable colleagues such as Isao Kawamoto and Yasuo Shimoji. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Katsuhiko Kojima's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in antibacterial treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…